Antibiotic Indications and Appropriateness in the Pediatric Intensive Care Unit: A 10-Center Point Prevalence Study
Kathleen Chiotos(Children's Hospital of Philadelphia), Jeffrey S. Gerber, Erika Stalets(University of Cincinnati Medical Center), Jennifer Blumenthal(Boston Children's Hospital), Hillary Crandall(University of Utah), Pranita D. Tamma(Johns Hopkins University), Jason G. Newland(Washington University in St. Louis), Robert Kavanagh(Penn State Milton S. Hershey Medical Center), Juri Boguniewicz(University of Colorado Denver), Hannah Stinson(Children's Hospital of Philadelphia), Stephanie S. Cabler(Washington University in St. Louis), Emily Berkman(Seattle Children's Hospital), Debra L. Palazzi(Baylor College of Medicine), Jessica Rubens(Johns Hopkins University)
Cited by 20
Related Papers
Infectious Diseases Society of America 2022 Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and <i>Pseudomonas aeruginosa</i> with Difficult-to-Treat Resistance (DTR-<i>P. aeruginosa</i>)
|Clinical Infectious Diseases|2022|484
Management of Neonates Born at ≥35 0/7 Weeks’ Gestation With Suspected or Proven Early-Onset Bacterial Sepsis
|PEDIATRICS|2018|462